Impact of BMI on Survival Outcomes of Immunotherapyin Solid Tumors: A Systematic Review

Impact of BMI on Survival Outcomes of Immunotherapyin Solid Tumors: A Systematic Review

Growing research has focused on obesity as a prognostic factor during therapy with immune-checkpoint inhibitors (ICIs). The role of body-mass index (BMI) in predicting response and toxicity to ICIs is not clear, as studies have shown inconsistent results and significant interpretation biases. We per...

Full description

Bibliographic Details
Main Authors: Alice Indini, Erika Rijavec, Michele Ghidini, Gianluca Tomasello, Monica Cattaneo, Francesca BarbinClaudia Bareggi, Barbara Galassi, Donatella Gambini, Francesco Grossi
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:International Journal of Molecular Sciences
Subjects:
obesity
cancer
immunotherapy
survival
irAEs
anti-PD1
Online Access:https://www.mdpi.com/1422-0067/22/5/2628

Internet

https://www.mdpi.com/1422-0067/22/5/2628

Similar Items